4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000899243-19-008569
Director acquired 20,576 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hayden Michael R · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 1 in the form | +20,576 | $3.38 | $69,547 | 50,924 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −20,576 | 0 | I |
Loading xslF345X03/doc4.xml…